Mion Décio, da Silva Giovanio Vieira, de Gusmão Josiane Lima, Machado Carlos Alberto, Amodeo Celso, Nobre Fernando, Praxedes José Nery, Mota Marco Antonio
Universidade de Hipertensão, Hospital das Clínicas, FMUSP, São Paulo, SP, Brazil.
Arq Bras Cardiol. 2007 Feb;88(2):212-7. doi: 10.1590/s0066-782x2007000200013.
To evaluate whether procedures adopted by Brazilian physicians in the diagnosis and treatment of hypertension are in compliance with those advocated by the IV Brazilian Hypertension Guidelines.
Survey carried out by means of telephone interviews with Brazilian physicians. The survey featured application of a questionnaire aimed to assess receipt of and compliance with the guidelines, and to evaluate various aspects regarding the treatment of hypertensive patients.
68.3% of the respondents had received the guidelines and answered the questionnaire in full. The total sample consisted of 483 physicians--47% cardiologists, 31.7% internists, and 21.3% nephrologists. The survey showed high compliance with certain guideline topics such as more than one measurement at different times for the diagnosis of hypertension (94%), and providing guidance regarding lifestyle changes as a therapeutic strategy. As to arterial pressure levels used for diagnosis and therapeutic target, compliance with guideline recommendations lacks uniformity. The survey showed a clear preference for pressure levels lower than those recommended, especially in patients with comorbidities. Attempts to assess cardiovascular risk also proved to be low. Only 64.7% of the respondents reported that they seek to determine the presence of diabetes mellitus, and 56.4% check for dyslipidemia. The majority (59.3%) mentioned diuretics as the preferred drug class for initial drug treatment of hypertension.
We concluded that there is only partial compliance with Brazilian Hypertension Guidelines and that certain factors should be taken into consideration when drawing up future guidelines, such as: improved distribution; standardization of values for diagnosis and therapeutic target; more extensive coverage of ways for physicians to approach hypertensive patients to better evaluate their overall cardiovascular risk.
评估巴西医生在高血压诊断和治疗中所采用的程序是否符合巴西第四次高血压指南所倡导的程序。
通过对巴西医生进行电话访谈开展调查。该调查采用了一份问卷,旨在评估对指南的接受情况和遵循情况,并评估高血压患者治疗的各个方面。
68.3%的受访者已收到指南并完整回答了问卷。总样本包括483名医生,其中47%为心脏病专家,31.7%为内科医生,21.3%为肾病专家。调查显示,在某些指南主题方面具有较高的遵循度,例如在高血压诊断时不同时间进行多次测量(94%),以及将生活方式改变作为治疗策略提供指导。至于用于诊断和治疗目标的动脉压水平,对指南建议的遵循缺乏一致性。调查显示,明显倾向于低于推荐水平的血压值,尤其是在合并症患者中。评估心血管风险的尝试也证明较少。只有64.7%的受访者表示他们试图确定糖尿病的存在,56.4%的受访者检查血脂异常情况。大多数(59.3%)提到利尿剂是高血压初始药物治疗的首选药物类别。
我们得出结论,对巴西高血压指南仅部分遵循,并且在制定未来指南时应考虑某些因素,例如:改善指南分发;诊断和治疗目标值的标准化;更广泛地涵盖医生诊治高血压患者的方式,以更好地评估其总体心血管风险。